
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.210 | 0.760 | 0.550 |
Shares | 99.790 | 99.790 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.757 | 19.998 |
Price to Book | 3.155 | 3.937 |
Price to Sales | 2.502 | 2.313 |
Price to Cash Flow | 15.031 | 15.604 |
Dividend Yield | 1.281 | 1.427 |
5 Years Earnings Growth | 14.798 | 11.202 |
Number of long holdings: 69
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 6.22 | 295.57 | -0.37% | |
Medincell | FR0004065605 | 5.28 | 16.32 | +2.97% | |
Eli Lilly | US5324571083 | 4.49 | 713.71 | -0.21% | |
Becton Dickinson | US0758871091 | 3.34 | 171.38 | -0.54% | |
AstraZeneca | GB0009895292 | 3.16 | 10,436.0 | +0.60% | |
Boston Scientific | US1011371077 | 3.12 | 104.50 | 0.00% | |
Fresenius SE | DE0005785604 | 3.03 | 43.150 | -0.51% | |
Merck&Co | US58933Y1055 | 2.80 | 77.58 | -0.33% | |
Novartis | CH0012005267 | 2.70 | 92.76 | -0.26% | |
Thermo Fisher Scientific | US8835561023 | 2.70 | 393.66 | -1.70% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pluvalca Disruptive Opportunities A | 104.85M | -5.76 | -7.00 | - | ||
Pluvalca Initiatives PME A | 76.64M | 4.91 | -6.13 | 6.18 | ||
Pluvalca France Small Caps A | 68.45M | 2.05 | -2.81 | 3.28 | ||
Pluvalca Allcaps A | 55.96M | 4.80 | 3.84 | 4.71 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review